ロード中...
Zoledronic acid exacerbates inflammation through M1 macrophage polarization
BACKGROUND: Zoledronic acid (Zol), one of the bisphosphonates, is frequently utilized for the treatment of osteoporosis and bone metastasis. However, the onset of medication-related osteonecrosis of the jaw (MRONJ) following dental treatments has become a serious issue. We reported previously that o...
保存先:
| 出版年: | Inflamm Regen |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6015454/ https://ncbi.nlm.nih.gov/pubmed/29977413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41232-018-0074-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|